Festival of Biologics USA 2027

The Festival of Biologics USA is billed as America's most comprehensive biologics event, covering the start-to-finish of the industry across antibody therapies, cell and gene therapies, immunotherapies and biosimilars. It brings together the large-molecule therapy ecosystem — pharma and biotech companies, start-ups, academics, research institutes, regulators, patient groups, payers and investors — for two days of presentations, panels, roundtables and workshops.

The program spans the full biologics value chain, including early-stage discovery, modality engineering, translational medicine, clinical trials, manufacturing, fill/finish operations, commercialization and market access. Disease areas covered include oncology, chronic and acute inflammation, autoimmune diseases, infectious diseases and neurodegenerative diseases, while therapy tracks address antibody formats (mAbs, bispecifics, ADCs), cell therapy, gene therapy, vaccines, precision medicine and biosimilars.

For 2027 the event makes an East Coast move to Boston, one of the world's most densely concentrated life-science hubs. With a large conference agenda, an exhibition of leading solution providers and more than 12 hours of built-in one-to-one networking, it is designed for professionals who want to keep pace with advances across the entire biologics and ATMP landscape and build partnerships from discovery to market.